SCHEMBL27659658

SCHEMBL27659658

COc1c(F)c(F)c(NC(=O)OCc2ccccc2)c(C(=O)O)c1F

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 3/20 0.49
▸ MEN1 O00255 5/20 0.47
▸ KMT2A Q03164 5/20 0.47
▸ POLB P06746 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ CYP1A2 P05177 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ MGLL Q99685 2/20 0.43
▸ CASP3 P42574 1/20 0.42
▸ GFER P55789 1/20 0.42
▸ KAT2B Q92831 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28562202 0.74 SMN1; SMN2 (0.58) CYP2C9MEN1KMT2APOLBNPC1
SCHEMBL27633285 0.74 MEN1 (0.45) CYP2C9MEN1KMT2APOLBKDM4E
SCHEMBL24983834 0.72 KCNA3 (0.47) MEN1KMT2APOLBKDM4E
SCHEMBL7431588 0.72 SMN1; SMN2 (0.52) CYP2C9MEN1KMT2APOLBNPC1
SCHEMBL8706375 0.70 SMN1; SMN2 (0.50) CYP2C9MEN1KMT2APOLBNPC1
SCHEMBL5233194 0.69 NPC1 (0.51) CYP2C9MEN1KMT2APOLBNPC1
SCHEMBL12474651 0.69 MGLL (0.51) CYP2C9POLBNPC1RAB9ASMN1; SMN2
SCHEMBL9861538 0.68 POLB (0.49) MEN1KMT2APOLBKDM4ENPC1
SCHEMBL10686084 0.68 HPGD (0.52) CYP2C9MEN1KMT2APOLBNPC1
SCHEMBL7553158 0.68 CASP3 (0.54) CYP2C9KMT2APOLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1863769-A Process for preparing aminopyrrolidine derivatives and intermediate compounds TEIJIN PHARMA LTD (JP) 2006-11-15 — — CN disclosed
Send feedback